DOCSLIB.ORG

(12) United States Patent (10) Patent No.: US 9,499,574 B2 Miodragovic Et Al

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
(12) United States Patent (10) Patent No.: US 9,499,574 B2 Miodragovic Et Al USOO94995.74B2 (12) United States Patent (10) Patent No.: US 9,499,574 B2 Miodragovic et al. (45) Date of Patent: Nov. 22, 2016 (54) ARSENOPLATIN ANTI-CANCERAGENTS OTHER PUBLICATIONS (71) Applicant: Northwestern University, Evanston, IL Miodragovic et al. Angewandte Chemie, International Edition (US) (2013), 52(41), 10749-10752.* International Search Report dated Nov. 13, 2013. (72) Inventors: Denana U. Miodragovic, Chicago, IL Anderson et al., “An expanded genetic code with a functional (S. home V. O'Halloran,9 Chicago, 7571quadruplet (2004). codon.” Proc. Natl. Acad. Sci. U.S.A. 101 (20):7566 Bacher et al., “Selection and Characterization of Escherichia coli Variants Capable of Growth on an Otherwise Toxic Trvptophan (73) Assignee: Northwestern University, Evanston, IL Analogue.” Bacteriol. 183(18):5414-5425 (2001). ryptop (US) Budisa et al., “Proteins with (beta)-(thienopyrrolyl)alanines as alter native chromophores and pharmaceutically active amino acids.” (*) Notice: Subject to any disclaimer, the term of this Protein Sci. 10(7): 1281-1292 (2001). patent is extended or adjusted under 35 Chin et al., “An Expanded Eukaryotic Genetic Code.” Science U.S.C. 154(b) by 0 days. 301(5635):964-967 (2003). Hamano-Takaku et al., “A Mutant Escherichia coli Tyrosyl-tRNA (21) Appl. No.: 14/421,982 Synthetase Utilizes the Unnatural Amino Acid AZatyrosine More Efficiently than Tyrosine,” J. Biol. Chem. 275(51):40324-40328 (22) PCT Filed: Aug. 14, 2013 (2000). Ibba et al., “Genetic code: introducing pyrrolysine.” Curr Biol. 12(13):R464-R466 (2002). (86). PCT No.: PCT/US2013/0549.99 Ikeda et al., “Synthesis of a novel histidine analogue and its efficient S 371 (c)(1), incorporation into a protein in vivo..” Protein Eng. Des. Sel. (2) Date: Feb. 16, 2015 16(9):699-706 (2003). James et al., “Kinetic characterization of ribonuclease S mutants (87) PCT Pub. No.: WO2014/028653 containing photoisomerizable phenylaZophenylalanine residues.” Protein Eng. Des. Sel. 14(12):983-991 (2001). PCT Pub. Date: Feb. 20, 2014 Stadtman, “Selenocysteine.” Annu Rev Biochem. 65:83-100 (1996). (65) Prior Publication Data Stryer et al., Biochemistry, 5. Sup,th ed., Freeman and Company (2002). US 2015/0218195 A1 Aug. 6, 2015 Zhang et al., “Selective incorporation of 5-hydroxytryptophan into O O proteins in mammalian cells.” Proc. Natl. Acad. Sci. U.S.A. Related U.S. Application Data 101(24):8882-8887 (2004). (60) Provisional application No. 61/683,031, filed on Aug. * cited by examiner 14, 2012. (51) Soon (2006.01) Primary Examiner — Sudhakar Katakam C07F 15/00 (2006.01) F.74). 2. Att Orney, Agent,Agent or Firm - Klintworth1WO & ROZa blat C07F 15/04 (2006.01) C07F 9/90 (2006.01) C07F 9/94 (2006.01) (57) ABSTRACT C07F 9/70 (2006.01) (52) U.S. Cl. Disclosed are compound having the structure of formula (I): CPC ............... C07F 19/005 (2013.01); C07F 9/70 (2013.01); C07F 9/902 (2013.01); C07F 9/94 (2013.01); C07F 15/0013 (2013.01); C07F X (I) 15/0066 (2013.01); C07F 15/045 (2013.01) (58) Field of Classification Search Al-y- & CPC ........ C07F 19/005; CO7F 9/70; C07F 9/902; L w L2 C07F 9/94; C07F 15/045; CO7F 15/0013; \,, g s CO7F 15/0066 Z -j-Z See application file for complete search history. Yi Y2 (56) References Cited wherein M is Pt, Pd or Ni; Q is As, Sb or Bi; Z' is N: Z is U.S. PATENT DOCUMENTS O or S; L and L are independently C(O), C R' or C R: X is a Lewis base and Y and Y are independently oxygen 2004/0258759 A1 12, 2004 SuSlick et al. or Sulfur-containing Substituents, conjugates containing FOREIGN PATENT DOCUMENTS compounds of formula (I) and their use as chemotherapy agents. CA 1196004 10, 1985 CN 1.01434622 5, 2009 EP O306605 3, 1989 12 Claims, 8 Drawing Sheets U.S. Patent Nov. 22, 2016 Sheet 1 of 8 US 9,499,574 B2 C1 FIG. 1A U.S. Patent Nov. 22, 2016 Sheet 2 of 8 US 9,499,574 B2 FIG. B U.S. Patent Nov. 22, 2016 Sheet 3 of 8 US 9,499,574 B2 O O-2cs Y5 -& C FIG. 1C U.S. Patent Nov. 22, 2016 Sheet 4 of 8 US 9,499,574 B2 FIG. 1D U.S. Patent Nov. 22, 2016 Sheet S of 8 US 9,499,574 B2 H 2.18(ppm) 2.14 2.10 Nois & Sois & -3724 ppm -386 ppm Jaspesin a 456 Hz -3710 -3750 -3790 -3830 -38to FIG 2 U.S. Patent Nov. 22, 2016 Sheet 6 of 8 US 9,499,574 B2 A2780CP K Complex 1 00 e Cisplatin & Arsenic trioxide 50 haarara Control.0 5 2.0 2.5 3.0 LogM/u M HTC 116 K Complex 1 e Cisplatin & Arsenic trioxide LogM/LM FG. 3 U.S. Patent Nov. 22, 2016 Sheet 7 of 8 US 9,499,574 B2 U87 a Complex 1 9 Cisplatin 00- s : x & Arsenic trioxide 50 O NS i. orrooroo LogM/u M D A2780 50 Complex 1 0 Cisplatin C & Arsenic trioxide ass 00 -k-k s XX 98. xA as a O) as N. N. St 50 O 8 On . aga i. hoovoo Control O 2 3 LogM/u M FIG. 3 (Cont.) U.S. Patent Nov. 22, 2016 Sheet 8 of 8 US 9,499,574 B2 E MDA-MB-231-mCherry 150 Complex 1 e Cisplatin 100 is is S- a Arsenic trioxide SS58 l r re. Control - O 2 3 LogM/M F RPM 8226 150 Complex 1 C e Cisplatin is 100 = -s & Arsenic trioxide 9 & X O) as a teen O Control -1 O 2 3 LogM/u M FIG. 3 (Cont.) US 9,499,574 B2 1. 2 ARSENOPLATIN ANT-CANCERAGENTS X (I) CROSS-REFERENCE TO RELATED APPLICATIONS A.z-- y The present application is the National Stage of Interna Z2-Q-Z2 tional Application No. PCT/US2013/054999, filed Aug. 14, M. v. 2013, and entitled “ARSENOPLATIN ANTI-CANCER Yi Y2 AGENTS, which claims the benefit of U.S. Provisional 10 Application No. 61/683,031 filed Aug. 14, 2012, and entitled wherein M is Pt, Pd or Ni; Q is As, Sb or Bi; Z' is N: Z is ARSENOPLATINS-A NEW CLASS OF ANTI-CANCER O or S; L and L are independently C(O), C R' or C R: AGENTS. The content of the U.S. Provisional Patent X is a Lewis base; Y' and Y are independently selected Application is hereby incorporated by reference in its from —OR. -OR', SR and SR, wherein R' and Rare entirety. 15 independently selected from hydrogen, halogen, cyano, keto, ester, ether, thiol, thioether, thioester, imino, C-Co STATEMENT REGARDING FEDERALLY alkyl, C-Co alkenyl, alkynyl, alkoxyl, amino, amidyl, SPONSORED RESEARCH OR DEVELOPMENT immino, Sulfonyl, Sulfoxyl, phosphoryl, phosphoryl ester, glycosyl, aryl, C-C cycloalkyl, heteroaryl, and C-Cls This invention was made with government Support under heterocycloalkyl: grant numbers U01 CA151461, U54 CA119341, U54 wherein R and Rare independently selected from hydro CA143869, P50 CA090386 awarded by the National Insti gen, C-C alkyl, C-Coalkenyl, alkynyl, alkoxyl, amino, tutes of Health and grant number W81XWH-08-1-0672 amidyl, immino, Sulfonyl, Sulfoxyl, phosphoryl, phosphoryl awarded by the US Army Medical Research and Materiel ester, glycosyl, aryl, C-C cycloalkyl, heteroaryl, and Command. The government has certain rights in the inven 25 C-Cls heterocycloalkyl; tion. wherein the Lewis base can be halogen, N-bonded cyano, nitroso, nitroxyl, N-bonded C-C alkyl, C-C alkenyl, BACKGROUND N-bonded C-C cycloalkyl, N-bonded C-Coheteroalkyl, N-bonded C-Co heteroalkenyl, N-bonded aryl, N-bonded 1. Technical Field 30 heteroaryl, N-bonded C-Cls heterocycloalkyl, NR'R''. The disclosure relates to arsenoplatin and related com N-bonded ligand, S-bonded cyano, sulfonyl, sulfoxyl, thiol, pounds and methods for their use as chemotherapy agents. S-bonded thioether, S-bonded thioester, S-bonded C-Co 2. Description of Relevant Prior Art alkyl, C-Co alkenyl, S-bonded C-Co cycloalkyl, Cis-diamminedichloroplatinum(II) ("Cisplatin') and S-bonded C-Coheteroalkyl, S-bonded C-C heteroalk 35 enyl, S-bonded aryl, S-bonded heteroaryl, S-bonded C-Cls arsenic trioxide (ASOs) are highly successful agents for heterocycloalkyl, - SR, S-bonded ligand, O-bonded treatment of cancer. Cisplatin is used in combination che C-C cycloalkyl, O-bonded C-C heteroalkyl, O-bonded motherapy to treat ovarian, testicular, head, neck, and blad C-Co heteroalkenyl, O-bonded aryl, O-bonded heteroaryl, der cancers. Unfortunately, these and other cancers fre O-bonded C-Cls heterocycloalkyl, —OR, O-bonded car quently develop resistance to this widely used agent and 40 boxylato, O-bonded polycarboxylato, O-bonded carboxy there are intensive efforts to develop new agents that over lato, O-bonded polycarboxylato, O-bonded carboxylato, come this resistance. Arsenic trioxide, which was discovered O-bonded polycarboxylato, O-bonded ligand, or P-bonded as a traditional Chinese medicine, is a front line treatment phosphine having formula P(R)-(R), where x is 0, 1, 2 for acute promyelocytic leukemia and has also shown pre or 3: liminary efficacy in the treatment of blood cancers such as 45 wherein R and Rare independently selected from hydro multiple myeloma and myelodysplastic syndromes. gen, O. —CO.R. —COR, C-Clo alkyl, C-Coalkenyl, Both compounds induce apoptotic cell death, but through aryl, heteroaryl, C-C cycloalkyl and C-Cls heterocy different pathways. Cisplatin reacts with DNA and causes cloalkyl; intra- and inter-strand DNA cross-links. The principal com wherein R and Rare independently selected from C-Co ponent of aqueous Solutions of ASO at pH 7.
Load more

Recommended publications
  • Step-By-Step Guide to Better Laboratory Management Practices
    Step-by-Step Guide to Better Laboratory Management Practices Prepared by The Washington State Department of Ecology Hazardous Waste and Toxics Reduction Program Publication No. 97- 431 Revised January 2003 Printed on recycled paper For additional copies of this document, contact: Department of Ecology Publications Distribution Center PO Box 47600 Olympia, WA 98504-7600 (360) 407-7472 or 1 (800) 633-7585 or contact your regional office: Department of Ecology’s Regional Offices (425) 649-7000 (509) 575-2490 (509) 329-3400 (360) 407-6300 The Department of Ecology is an equal opportunity agency and does not discriminate on the basis of race, creed, color, disability, age, religion, national origin, sex, marital status, disabled veteran’s status, Vietnam Era veteran’s status or sexual orientation. If you have special accommodation needs, or require this document in an alternate format, contact the Hazardous Waste and Toxics Reduction Program at (360)407-6700 (voice) or 711 or (800) 833-6388 (TTY). Table of Contents Introduction ....................................................................................................................................iii Section 1 Laboratory Hazardous Waste Management ...........................................................1 Designating Dangerous Waste................................................................................................1 Counting Wastes .......................................................................................................................8 Treatment by Generator...........................................................................................................12
    [Show full text]
  • CHEM 301 Assignment #2 Provide Solutions to the Following Questions in a Neat and Well-Organized Manner
    CHEM 301 Assignment #2 Provide solutions to the following questions in a neat and well-organized manner. Reference data sources for any constants and state assumptions, if any. Due date: Thursday, Oct 20th, 2016 Attempt all questions. Only even numbers will be assessed. 1. A pond in an area affected by acid mine drainage is observed to have freshly precipitated Fe(OH)3(s) at pH 4. What is the minimum value of pe in this water? Use the appropriate pe-pH speciation diagram to predict the dominant chemical speciation of carbon, sulfur and copper under these conditions. 2. The solubility of FeS(s) in marine sediments is expected to be affected by the pH and the [H2S(aq)] in the surrounding pore water? Calculate the equilibrium concentration of Fe2+ (ppb) at pH 5 and pH 8, -3 assuming the H2S is 1.0 x 10 M. pKsp(FeS) = 16.84. + 2+ FeS(s) + 2 H (aq) ==== Fe (aq) + H2S 3. Boric acid is a triprotic acid (H3BO3); pKa1 = 9.24, pKa2 = 12.74 and pKa3 = 13.80. a) Derive an expression for the fractional abundance of H3BO3 as a function of pH b) Construct a fully labeled pH speciation diagram for boric acid over the pH range of 0 to 14 using Excel spreadsheet at a 0.2 pH unit interval. 4. At pCl- = 2.0, Cd2+ and CdCl+ are the only dominant cadmium chloride species with a 50% fractional abundance of each. + a) Calculate the equilibrium constant for the formation of CdCl (1). + - b) Derive an expression for the fractional abundance of CdCl as a function of [Cl ] and 1 – 4 for cadmium chloro species.
    [Show full text]
  • Arsenic (As33)
    NANO3D SYSTEMS LLC 1110 NE Circle Blvd., ATAMI/Bldg. 11, Corvallis, Oregon 97330-4254 T 503-927-4766| F 541-758-9320| http://www.nano3dsystems.com Arsenic (As33) Properties Arsenic is a silvery-white metalloid with an atomic mass of 74.92 u. As has a density of 5.73 g/cm3, a melting point of 814 oC, and a Brinell hardness of 1440 MPa. The most common compounds have As in the +3 and +5 states, while it also exists in other oxidation states such as -3, -2, -1, +1, +2, +4. Its standard electrode potential in respect to As+3 is +0.3V. Though stable in dry air, arsenic forms a golden-bronze tarnish upon exposure to humidity which eventually becomes a black surface layer. Arsenic makes arsenic acid with concentrated nitric acid, arsenous acid with dilute nitric acid, and arsenic trioxide with concentrated sulfuric acid. It does not react with water, alkalis, or non-oxidizing acids. As is estimated to be at average concentration of 1.5 parts per million (ppm) in the Earth's crust. Plating Solutions Arsenic can be electrochemically deposited from aqueous electrolytes, containing in g/l: a) Example #1. Arsenic trioxide – 90, sodium hydroxide – 110 ml/l, potassium sodium tartrate tetrahydrate (Rochelle salt) - 80 with pH ~8 at temperature of 15-25 oC, current density of 10 – 20 mA/cm2 and current efficiency of ~100%. b) Example #2. Arsenic trioxide – 120, sodium cyanide – 3.7, sodium hydroxide – 120 at temperature of 15-25 oC and current density of 3 – 22 mA/cm2. Arsenic clectrodeposition can be also performed from choline chloride/ethylene glycol deep eutectic solvent [1].
    [Show full text]
  • MICROBIAL METHYLATION and VOLATILIZATION of ARSENIC By
    MICROBIAL METHYLATION AND VOLATILIZATION OF ARSENIC by CORINNE RITA LEHR B. Sc., University of Calgary, 1994 A THESIS SUBMITTED IN PARTIAL FULFILMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY in THE FACULTY OF GRADUATE STUDIES (Department of Chemistry) We accept this thesis as conforming to the required standard THE UNIVERSITY OF BRITISH COLUMBIA March 2003 © Corinne Lehr, 2003 In presenting this thesis in partial fulfilment of the requirements for an advanced degree at the University of British Columbia, I agree that the Library shall make it freely available for reference and study. I further agree that permission for extensive copying of this thesis for scholarly purposes may be granted by the head of my department or by his or her representatives. It is understood that copying or publication of this thesis for financial gain shall not be allowed without my written permission. Department of C.()e<P^'f("y The University of British Columbia Vancouver, Canada Date OJ/W h 1 JOC'J ABSTRACT The basis of the "Toxic Gas Hypothesis" of Sudden Infant Death Syndrome (SIDS) is that the microorganisms present on infants bedding materials volatilize sufficient arsenic, antimony or phosphorus from these materials to be acutely toxic to an infant. The volatilization of arsenic by aerobic microorganisms isolated from new sheepskin bedding materials, as well as from materials used by a healthy infant and by an infant who perished of SIDS was examined. Three arsenic-methylating fungi were isolated from a piece of sheepskin bedding material on which an infant perished of SIDS. These fungi form trimethylarsenic(V) species, precursors to volatile trimethylarsine.
    [Show full text]
  • 1. Give the Correct Names for Each of the Compounds Listed Below. A
    1. Give the correct names for each of the compounds listed below. a) NaCl sodium chloride n) ZrS2 zirconium sulfide b) FrBr francium bromide o) AgI silver iodide c) KF potassium fluoride p) BaSe barium selenide d) RaS radium sulfide q) MgO magnesium oxide e) LiI lithium iodide r) LaBr3 lanthanum bromide f) Li3N lithium nitride s) Sr3N2 strontium nitride g) AlBr3 aluminum bromide t) Cd3As2 cadmium arsenide h) CdCl2 cadmium chloride u) Rb2Se rubidium selenide i) K2O potassium oxide v) Rb3N rubidium nitride j) InF3 indium fluoride w) BaF2 barium fluoride k) ZnO zinc oxide x) ZrTe2 zirconium telluride l) Y2O3 yttrium oxide y) Cs3P cesium phosphide m) CaTe calcium telluride z) Y2O3 yttrium oxide 2. Write the correct chemical formula for each of the following compounds. a) potassium bromide KBr n) potassium nitride K3N b) zinc bromide ZnBr2 o) aluminum bromide AlBr3 c) lithium iodide LiI p) zinc phosphide Zn3P2 d) scandium chloride ScCl3 q) magnesium sulfide MgS e) magnesium chloride MgCl2 r) hafnium chloride HfCl4 f) magnesium oxide MgO s) barium sulfide BaS g) hydrogen sulfide H2S t) tantalum oxide Ta2O5 h) gallium iodide GaI3 u) zirconium nitride Zr3N4 i) sodium oxide Na2O v) potassium selenide K2Se j) magnesium selenide MgSe w) germanium fluoride GeF4 k) calcium fluoride CaF2 x) francium phosphide Fr3P l) aluminum oxide Al2O3 y) zinc arsenide Zn3As2 m) beryllium chloride BeCl2 z) scandium telluride Sc2Te3 L. h. s. – Chemistry – Nomenclature – Answers – Page 1 3. Give the correct names for each of the compounds listed below. a) CaSO4 calcium
    [Show full text]
  • Chemical Resistance Guide
    04/16 CHEMICAL RESISTANCE GUIDE PRIMARY FLUID SYSTEMS INC. 1050 COOKE BLVD., BURLINGTON, ONTARIO L7T 4A8 TEL:(905)333-8743 FAX:(905)333-8746 1-800-776-6580 email: [email protected] www.primaryfluid.com INDEX PAGE Disclaimer .................................................................................................... 3 Material Guide .............................................................................................. 4 Chemical Guide ............................................................................................ 5 – 22 Chemical Formulas ...................................................................................... 23 - 35 2 Primary Fluid Systems Inc CALL TOLL FREE 1-800-776-6580 PRIMARY FLUID SYSTEMS INC. DISCLAIMER Primary Fluid Systems Inc. takes no responsibility for the enclosed information in use with product selection against chemical resistance. The data in the following tables were obtained from numerous sources in the industry, and believed to be reliable but cannot be guaranteed. The information is intended as a general guide for material selection. The end user should be aware of the fact that actual service conditions will affect the chemical resistance. It is recommended that you cross reference this guide with one or two others to insure consistency. All data provided is based on testing at 70ºF [21ºC]. Thermoplastics, Metals and Elastomers have outstanding resistance to a wide range of chemical reagents. Such resistance, however, is a function A* Excellent – No Effect both of
    [Show full text]
  • And Antimony(III) Aqueous Chemistry from 25 to 300°C
    Research Collection Doctoral Thesis UV spectrophotometric studies of arsenic(III) and antimony(III) aqueous chemistry from 25 to 300°C Author(s): Iakovleva, Valentina P. Publication Date: 2003 Permanent Link: https://doi.org/10.3929/ethz-a-004685440 Rights / License: In Copyright - Non-Commercial Use Permitted This page was generated automatically upon download from the ETH Zurich Research Collection. For more information please consult the Terms of use. ETH Library DISS. ETH No. 15343 UV SPECTROPHOTOMETRIC STUDIES OF ARSENIC(III) AND ANTIMONY(III) AQUEOUS CHEMISTRY FROM 25 TO 300°C. A dissertation submitted to the SWISS FEDERAL INSTITUTE OF TECHNOLOGY ZURICH for the degree of Doctor of Science presented by VALENTINA P. IAKOVLEVA Dipl. Geologist-Geochemist, Moscow State University, Russia born 19.05.1975 citizen of Russian Federation accepted on the recommendation of Prof. Dr. T. M. Seward Inst. Mineralogy and Pétrographie, ETH Zürich examiner Prof. Dr. C. A. Heinrich Inst. Isotope Geochemistry, ETH Zürich co-examiner Prof. Dr. S. A. Wood University of Idaho, Moscow, USA co-examiner 2003 The cover illustrations show: absorbance spectra oîAs(III) sulphide containing solutions; arsenic and antimony sulphide deposition on siliceous algal stromatolites at Champagne Pool, Waiotapu Geothermal System, New Zealand. To my grandfathers General A. M. Volkov Professor N. P. Zakaznov Abstract The aim of this study has been to provide a reliable set of experimentally based thermo¬ dynamic data which define the ionisation of arsenous and antimonous acids (i.e. HAsÖ2 and HzSbO^) and p-nitrophenol from 25 to 300°C at saturated vapour pressures. In addition, the stability and stoichiometry of the thioarsenite aqueous species have also been determined at ambient temperature.
    [Show full text]
  • Hydration of Arsenic Oxyacid Species and of Orthotelluric Acid
    This is an author produced version of a paper published in Dalton Transactions: an international journal of inorganic chemistry. This paper has been peer-reviewed but may not include the final publisher proof-corrections or pagination. Citation for the published paper: Mähler, Johan; Persson, Ingmar and Herbert, Roger B. (2013) Hydration of arsenic oxyacid species. DaltonTransactions: an international journal of inorganic chemistry. Volume: 42, Number: 5, pp 1364-1377. http://dx.doi.org/10.1039/c2dt31906c. Access to the published version may require journal subscription. Published with permission from: Royal Society of Chemistry. Epsilon Open Archive http://epsilon.slu.se Hydration of Arsenic Oxyacid Species Johan Mähler,a Ingmar Perssona and Roger Herbertb a Department of Chemistry, Swedish University of Agricultural Sciences, P.O.Box 7015, SE-750 07 Uppsala, Sweden, b Department of Earth Sciences, Uppsala University, Villavägen 16, SE-752 36 Uppsala, Sweden. E-mail: [email protected] Abstract The bond distances in hydrated arsenic oxyacid species in aqueous solution have been studied by EXAFS spectroscopy and large angle X-ray scattering, LAXS. These results have been compared to structures in the solid state, as found in an extensive survey of available crystal structures. Protonated oxygen atoms can be distinguished with a longer As-O distance for both arsenic(V) and arsenic(III) species in the crystalline state. However, the average (3-n)- As-O distance for the HnAsO4 species (0 ≤ n ≤3) remains the same. These average values are slightly shorter, ca. 0.02 Å, than in aqueous solution due to the hydration as determined by EXAFS and LAXS.
    [Show full text]
  • Arsenic Removal with a Dithiol Ligand Supported on Magnetic Nanoparticles
    University of Kentucky UKnowledge Theses and Dissertations--Chemistry Chemistry 2017 ARSENIC REMOVAL WITH A DITHIOL LIGAND SUPPORTED ON MAGNETIC NANOPARTICLES John Hamilton Walrod II University of Kentucky, [email protected] Author ORCID Identifier: https://orcid.org/0000-0003-1875-6546 Digital Object Identifier: https://doi.org/10.13023/ETD.2017.314 Right click to open a feedback form in a new tab to let us know how this document benefits ou.y Recommended Citation Walrod, John Hamilton II, "ARSENIC REMOVAL WITH A DITHIOL LIGAND SUPPORTED ON MAGNETIC NANOPARTICLES" (2017). Theses and Dissertations--Chemistry. 83. https://uknowledge.uky.edu/chemistry_etds/83 This Doctoral Dissertation is brought to you for free and open access by the Chemistry at UKnowledge. It has been accepted for inclusion in Theses and Dissertations--Chemistry by an authorized administrator of UKnowledge. For more information, please contact [email protected]. STUDENT AGREEMENT: I represent that my thesis or dissertation and abstract are my original work. Proper attribution has been given to all outside sources. I understand that I am solely responsible for obtaining any needed copyright permissions. I have obtained needed written permission statement(s) from the owner(s) of each third-party copyrighted matter to be included in my work, allowing electronic distribution (if such use is not permitted by the fair use doctrine) which will be submitted to UKnowledge as Additional File. I hereby grant to The University of Kentucky and its agents the irrevocable, non-exclusive, and royalty-free license to archive and make accessible my work in whole or in part in all forms of media, now or hereafter known.
    [Show full text]
  • United States Patent (19) 11 Patent Number: 4,769,230 Greco Et Al
    United States Patent (19) 11 Patent Number: 4,769,230 Greco et al. 45 Date of Patent: Sep. 6, 1988 54 PROCESS FOR PREPARATION OF ARSENIC 56) References Cited ACID U.S. PATENT DOCUMENTS 75 Inventors: Nicholas P. Greco; Byung K. Ahn, 1,650,860 1 1/1927 Askenasy et al. ................... 423/617 both of Pittsburgh, John J. Kozak, 1,974,747 3/1932 Latimer ............................... 423/617 Wexford, all of Pa. Primary Examiner-John Doll Assistant Examiner-Jackson Leeds 73) Assignee: Koppers Company, Inc., Pittsburgh, Attorney, Agent, or Firm-Donald M. MacKay; Herbert Pa. J. Zeh, Jr. 57 ABSTRACT 21 Appl. No.: 404,614 Arsenic acid is formed from arsenous acid and water 22 Filed: Aug. 2, 1982 under oxygen pressure with catalytic amounts of nitric acid and a halide whereby the nitric oxide by-product is regenerated to nitric acid for contact with fresh arse 51) Int. Cl. .............................................. C01G 28/00 nous acid. 52 U.S. Cl. .................................................... 423/617 58) Field of Search ......................................... 423/617 15 Claims, No Drawings 4,769,230 1 2 preferably from about 1 to about 5%. Dilute nitric acid PROCESS FOR PREPARATION OF ARSENIC of about 1 to about 5% is most preferred becaused there ACD is little nitric acid in the product. The use of more con centrated nitric acid requires separation steps such as BACKGROUND OF THE INVENTION 5 distillation to remove it or it can be recycled back to Arsenic Acid is useful in preparing wood preserva feed arsenic trioxide. Less than a stoichiometric amount tives. It is prepared commercially by the nitric acid or of nitric acid is required such as between about 2 and hydrogen peroxide oxidation of arsenous acid.
    [Show full text]
  • 1997-11-19 Arsenic and Compounds As
    ARSENIC AND COMPOUNDS Inorganic Arsenic was identified as a toxic air contaminant under California's air toxics program (AB 1807) in 1990. Arsenic compounds (inorganic including arsine) are federal hazardous air pollutants and were identified as toxic air contaminants in April 1993 under AB 2728. CAS Registry Number: 7440-38-2 As Molecular Formula: As Arsenic is a silver-grey brittle, crystalline (hexagonal, rhombic), metallic-looking substance which exists in three allotropic forms (yellow, black, and grey). It is odorless and nearly tasteless. Arsenic is soluble in nitric acid, cold hydrochloric, and sulfuric acids. It is insoluble in water and nonoxidizing acids. Arsenic compounds are generally non-volatile except for gaseous arsines and arsenic trioxide. Arsenic trioxide is a solid at room temperature but sublimes at 193 oC (Merck, 1989; ARB, 1990g). Table I lists some physical and chemical properties of arsenic compounds. Physical Properties of Arsenic Synonyms: arsenic black; arsenicals; colloidal arsenic; grey arsenic; metallic arsenic; arsenic-75 Molecular Weight: 74.92 Valence: 3,5 Boiling Point: Sublimes at 612 oC Melting Point: 817.0 oC at 28 atm Vapor Pressure: 1.0 mm Hg at 372 oC Density/Specific Gravity: 5.727 at 14 oC (HSDB, 1995; Merck, 1989; Sax, 1989; U.S. EPA, 1994a) SOURCES AND EMISSIONS A. Sources Combustion and high-temperature processes are the largest sources of inorganic arsenic emissions to the atmosphere (ARB, 1990g). Arsenic is used in metallurgy for hardening copper, lead, and alloys. It is also used in the manufacturing of certain types of glass (Merck, 1989). Toxic Air Contaminant Identification List Summaries - ARB/SSD/SES September 1997 75 Arsenic and Compounds Most commercial arsenic products are manufactured using arsenic trioxide as the raw material which serves as the basis for approximately 50 other arsenic compounds produced in the United States (ARB, 1990g).
    [Show full text]
  • [email protected] +1-703-527-3887 (International) Website
    Date of Issue: 07 February 2018 SAFETY DATA SHEET 1. SUBSTANCE AND SOURCE IDENTIFICATION Product Identifier SRM Number: 3037 SRM Name: Arsenous Acid (AsIII) Standard Solution Other Means of Identification: Not applicable. Recommended Use of This Material and Restrictions of Use This Standard Reference Material (SRM) is intended for use as a primary calibration standard for the quantitative determination of the arsenic species arsenous acid (AsIII). This SRM can be used for quality assurance when assigning values to in-house control materials. A unit of SRM 3037 consists of two 10 mL sealed borosilicate glass amber ampoules of an acidified aqueous solution prepared gravimetrically to contain a known mass fraction of arsenous acid. The solution contains hydrochloric acid at a volume fraction of approximately 1 %, which is equivalent to a concentration (molarity) of approximately 0.12 mol/L. Due to digestion of the starting material, arsenic trioxide, with sodium hydroxide, sodium is present in the ampoules at approximately 1000 mg/kg. Company Information National Institute of Standards and Technology Standard Reference Materials Program 100 Bureau Drive, Stop 2300 Gaithersburg, Maryland 20899-2300 Telephone: 301-975-2200 Emergency Telephone ChemTrec: FAX: 301-948-3730 1-800-424-9300 (North America) E-mail: [email protected] +1-703-527-3887 (International) Website: http://www.nist.gov/srm 2. HAZARDS IDENTIFICATION Classification Physical Hazard: Corrosive to metals Category 1 Health Hazard: Carcinogenicity Category 1A Label Elements Symbol Signal Word DANGER Hazard Statement(s) H290 May be corrosive to metals. H350 May cause cancer through inhalation. Precautionary Statement(s) P201 Obtain special instructions before use.
    [Show full text]